This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ulsh, L S
Right arrow Articles by Shih, T Y
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ulsh, L S
Right arrow Articles by Shih, T Y

 Previous Article  |  Next Article 

Mol Cell Biol. 1984 August; 4(8): 1647-1652

Metabolic turnover of human c-rasH p21 protein of EJ bladder carcinoma and its normal cellular and viral homologs.

L S Ulsh and T Y Shih

ABSTRACT

The EJ bladder carcinoma oncogene is activated by a point mutation in the c-rasH proto-oncogene at the 12th amino acid codon. In an attempt to understand the mechanism of oncogenic activation, a comparative study was undertaken to examine the metabolic turnover and subcellular localization of the p21 protein encoded by the EJ oncogene, the viral oncogene, and its normal cellular homolog. Pulse-labeling experiments indicated that both c-ras p21 proteins were synthesized by a very similar pathway, as was observed for the viral p21 protein of Harvey murine sarcoma virus. The pro-p21 proteins were detected in free cytosol, and the processed products were associated with plasma membrane. The intracellular half-life of p21 proteins was determined by pulse-labeling and chasing in the presence of excess unlabeled methionine. Although both p21 proteins of EJ and the normal c-ras genes which are not phosphorylated have a half-life of 20 h, the viral p21 protein of Harvey murine sarcoma virus which includes a phosphorylated form is much more stable in cells, having a half-life of 42 h, apparently due to phosphorylation.


Mol Cell Biol. 1984 August; 4(8): 1647-1652




This article has been cited by other articles:

  • Saxowsky, T. T., Meadows, K. L., Klungland, A., Doetsch, P. W. (2008). 8-Oxoguanine-mediated transcriptional mutagenesis causes Ras activation in mammalian cells. Proc. Natl. Acad. Sci. USA 105: 18877-18882 [Abstract] [Full Text]  
  • Marks, R. E., Ho, A. W., Robbel, C., Kuna, T., Berk, S., Gajewski, T. F. (2007). Farnesyltransferase inhibitors inhibit T-cell cytokine production at the posttranscriptional level. Blood 110: 1982-1988 [Abstract] [Full Text]  
  • Psahoulia, F. H., Moumtzi, S., Roberts, M. L., Sasazuki, T., Shirasawa, S., Pintzas, A. (2007). Quercetin mediates preferential degradation of oncogenic Ras and causes autophagy in Ha-RAS-transformed human colon cells. Carcinogenesis 28: 1021-1031 [Abstract] [Full Text]  
  • Clark, S. S., Zhong, L., Filiault, D., Perman, S., Ren, Z., Gould, M., Yang, X. (2003). Anti-Leukemia Effect of Perillyl Alcohol in Bcr/Abl-Transformed Cells Indirectly Inhibits Signaling through Mek in a Ras- and Raf-Independent Fashion. Clin. Cancer Res. 9: 4494-4504 [Abstract] [Full Text]  
  • Sauzeau, V., Rolli-Derkinderen, M., Marionneau, C., Loirand, G., Pacaud, P. (2003). RhoA Expression Is Controlled by Nitric Oxide through cGMP-dependent Protein Kinase Activation. J. Biol. Chem. 278: 9472-9480 [Abstract] [Full Text]  
  • Fiordalisi, J. J., Holly, S. P., Johnson, R. L. II, Parise, L. V., Cox, A. D. (2002). A Distinct Class of Dominant Negative Ras Mutants. CYTOSOLIC GTP-BOUND Ras EFFECTOR DOMAIN MUTANTS THAT INHIBIT Ras SIGNALING AND TRANSFORMATION AND ENHANCE CELL ADHESION. J. Biol. Chem. 277: 10813-10823 [Abstract] [Full Text]  
  • Holstein, S. A., Wohlford-Lenane, C. L., Hohl, R. J. (2002). Consequences of Mevalonate Depletion. DIFFERENTIAL TRANSCRIPTIONAL, TRANSLATIONAL, AND POST-TRANSLATIONAL UP-REGULATION OF Ras, Rap1a, RhoA, AND RhoB. J. Biol. Chem. 277: 10678-10682 [Abstract] [Full Text]  
  • Rose, W. C., Lee, F. Y. F., Fairchild, C. R., Lynch, M., Monticello, T., Kramer, R. A., Manne, V. (2001). Preclinical Antitumor Activity of BMS-214662, a Highly Apoptotic and Novel Farnesyltransferase Inhibitor. Cancer Res. 61: 7507-7517 [Abstract] [Full Text]  
  • Graham, T. E., Key, T. A., Kilpatrick, K., Dorin, R. I. (2001). Dexras1/AGS-1, a Steroid Hormone-Induced Guanosine Triphosphate-Binding Protein, Inhibits 3',5'-Cyclic Adenosine Monophosphate-Stimulated Secretion in AtT-20 Corticotroph Cells. Endocrinology 142: 2631-2640 [Abstract] [Full Text]  
  • WEISS, R. H., RAMIREZ, A., JOO, A. (1999). Short-Term Pravastatin Mediates Growth Inhibition and Apoptosis, Independently of Ras, via the Signaling Proteins p27Kip1 and PI3 Kinase. J. Am. Soc. Nephrol. 10: 1880-1890 [Abstract] [Full Text]  
  • Raiteri, M., Arnaboldi, L., Mcgeady, P., Gelb, M. H., Verri, D., Tagliabue, C., Quarato, P., Ferraboschi, P., Santaniello, E., Paoletti, R., Fumagalli, R., Corsini, A. (1997). . J. Pharmacol. Exp. Ther. 281: 1144-1153 [Abstract] [Full Text]  
  • Hohl, R. J., Lewis, K. (1995). Differential Effects of Monoterpenes and Lovastatin on RAS Processing. J. Biol. Chem. 270: 17508-17512 [Abstract] [Full Text]  
  • Moore, G., Ayabe, T, Visconti, P., Schultz, R., Kopf, G. (1994). Roles of heterotrimeric and monomeric G proteins in sperm-induced activation of mouse eggs. Development 120: 3313-3323 [Abstract]